Evidence map›Paper›PMID 34224155›Full record

ArticleJournal of medical virology2021

What does COVID-19 testing results really say? The real statistics concealed behind the accessible data.

Asma Rashki, Amirhoshang Hoseinpour Dehkordi, Reza Nemati, Pouya Tavousi

Erratum issuedAbstract read
In one paragraph

Article in Journal of medical virology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Evolution of Responses to COVID-19 and Epidemiological Characteristics in South Korea.International journal of environmental research and public health · 2022
    Article
  2. Corrigendum.Journal of medical virology · 2022
    Article
  3. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

4 authors.

Asma RashkiDepartment of Pharmacology, School of Medicine, Zahedan University of Medicine, Zahedan, Sistan and Balouchetsan Province, Iran.ORCID 0000-0002-6134-5948
Amirhoshang Hoseinpour DehkordiSchool of Computer Science, Institute for Research in Fundamental Sciences, Tehran, Iran.ORCID 0000-0002-6386-7037
Reza NematiBiotherapeutic and Medicinal Sciences, Biogen Inc., Cambridge, Massachusetts, USA.
Pouya TavousiUConn Tech Park, University of Connecticut, Storrs, Connecticut, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Accurate and comprehensive testing is crucial for practitioners to portray the pandemic. Without testing there is no data; yet, the exact number of infected people cannot be determined due to the lack of comprehensive testing. The number of seropositive for SARS-CoV-2 infection is obviously relative to the extent of testing. However, the true number of infections might be still far higher than the reported values. To compare the countries based on the number of seropositive for SARS-CoV-2 infection is misleading, as there may not be enough tests being carried out to properly monitor the outbreak. In this paper, we closely look through the COVID-19 testing results. Herein, we try to draw conclusions based on the reported data: first, the presence of a possible relationship between COVID-19 transition and patients' age will be assessed. Then, the COVID-19 case fatality rate (CFR) is compared with the age-demographic data for different countries. Based on the results, a method for estimating a lower bound (minimum) for the number of actual positive cases will be developed and validated. Results of this study have shown that CFR is a metric reflecting the spread of the virus, but is a factor of the extent of testing and does not necessarily show the real size of the outbreak. Moreover, no large difference in susceptibility by age has been found. The results suggest the similarity between the age distribution of COVID-19 and the population age-demographic is improving over the course of the pandemic. In addition, countries with lower CFRs have a more similar COVID-19 age distribution, which is a result of more comprehensive testing. Finally, a method for estimation of the real number of infected people based on the age distributions, reported CFRs, and the extent of testing will be developed and validated.

Indexed as

AdolescentAdultAgedAged, 80 and overAge DistributionChildChild, PreschoolCOVID-19COVID-19 TestingHumansInfantInfant, NewbornMiddle AgedMortalityPandemicsSARS-CoV-2age-demographicCFRCOVID-19estimationpandemicspread

Identifiers

PMID34224155
PMCPMC8426950

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.